Propofol (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Propofol drug offered from Actavis Pharma, Inc.. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Propofol |
SUBSTANCE NAME: | PROPOFOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | General Anesthesia [PE],General Anesthetic [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, EMULSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-12-28 |
END MARKETING DATE: | 0000-00-00 |
Propofol HUMAN PRESCRIPTION DRUG Details:
Item Description | Propofol from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2015-12-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-2136_b2ee1715-2baa-4b7e-98ae-da3fe34184c0 |
PRODUCT NDC: | 0591-2136 |
APPLICATION NUMBER: | ANDA205307 |
Other PROPOFOL Pharmaceutical Manufacturers / Labelers: